131 related articles for article (PubMed ID: 29488720)
1. [Expression and prognostic value of memory T lymphocyte in patients with non-small cell lung cancer following radiotherapy].
Hu J; Zheng L; Zhang H; Zhang S; Xu G
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):523-528. PubMed ID: 29488720
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.
Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X
Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781
[TBL] [Abstract][Full Text] [Related]
3. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
Yan Y; Wang X; Liu C; Jia J
BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer.
Eberst G; Vernerey D; Laheurte C; Meurisse A; Kaulek V; Cuche L; Jacoulet P; Almotlak H; Lahourcade J; Gainet-Brun M; Fabre E; Le Pimpec-Barthes F; Adotevi O; Westeel V
BMC Cancer; 2022 May; 22(1):529. PubMed ID: 35546670
[TBL] [Abstract][Full Text] [Related]
5. WASp Deficiency Selectively Affects the TCR Diversity of Different Memory T Cell Subsets in WAS Chimeric Mice.
Li W; Jia Y; Wang Y; Zhao Q; Yang L; Zeng T; Niu L; Dai R; Li Y; Zhao X; Wu J
Front Immunol; 2021; 12():794795. PubMed ID: 35116029
[TBL] [Abstract][Full Text] [Related]
6. Peripheral memory T-cell profile is modified in patients undergoing periodontal management.
Medara N; Lenzo JC; Walsh KA; Holden JA; Reynolds EC; Darby IB; O'Brien-Simpson NM
J Clin Periodontol; 2021 Feb; 48(2):249-262. PubMed ID: 33131124
[TBL] [Abstract][Full Text] [Related]
7. [Effect and Clinical Significance of Bortezomib and Thalidomide on the Memory T Cells Subsets and Regulatory T Cells in Peripheral Blood of Patients with Multiple Myeloma].
Shi LL; Li HQ; Mei JG; Zhou XG; Li F; Song P; Zhai YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):477-483. PubMed ID: 29665919
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first-line therapy administration in patients with chronic lymphocytic leukemia.
Vodárek P; Écsiová D; Řezáčová V; Souček O; Šimkovič M; Vokurková D; Belada D; Žák P; Smolej L
Cancer Med; 2023 Mar; 12(6):6956-6970. PubMed ID: 36440594
[TBL] [Abstract][Full Text] [Related]
9. The Relationship between Lymphocyte Subsets and the Prognosis and Genomic Features of Lung Cancer: A Retrospective Study.
Dai S; Ren P; Ren J; Yang L; Li W
Int J Med Sci; 2021; 18(10):2228-2234. PubMed ID: 33859531
[No Abstract] [Full Text] [Related]
10. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
[No Abstract] [Full Text] [Related]
11. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Pembrolizumab on T Lymphocyte Subsets in Patients with Advanced
Non-small Cell Lung Cancer and Its Therapeutic Effect].
Wang Y; Wang Y; Jiang M; Zhao Y; Zhang X
Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):182-187. PubMed ID: 33819968
[TBL] [Abstract][Full Text] [Related]
13. Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer.
Liu C; Hu Q; Hu K; Su H; Shi F; Kong L; Zhu H; Yu J
J Transl Med; 2019 Apr; 17(1):120. PubMed ID: 30971280
[TBL] [Abstract][Full Text] [Related]
14. Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression.
Wang Y; Zhou N; Zhu R; Li X; Sun Z; Gao Y; Liu W; Meng C; Ge Y; Bai C; Li T; Liu H
BMC Pulm Med; 2021 Sep; 21(1):282. PubMed ID: 34488711
[TBL] [Abstract][Full Text] [Related]
15. Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
Zheng Y; Shi A; Wang W; Yu H; Yu R; Li D; Xu B; Ma H; You J; Zhao D; Jiang L; Geng J; Zhu G
Clin Lung Cancer; 2018 Jul; 19(4):e399-e404. PubMed ID: 29519614
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics and prognostic value of peripheral blood T lymphocyte subsets in patients with severe influenza].
Geng TR; Han Y; Qiu ZF; Du TK; Jiang W; Shi JH; Qin T; Fan HW; Li TS
Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):200-206. PubMed ID: 32146746
[No Abstract] [Full Text] [Related]
17. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.
Liu C; Jing W; An N; Li A; Yan W; Zhu H; Yu J
J Transl Med; 2019 Oct; 17(1):344. PubMed ID: 31623615
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and functional characterizations of CD8
Zhang Y; Li W; Zhai J; Jin Y; Zhang L; Chen C
Exp Cell Res; 2022 Aug; 417(1):113212. PubMed ID: 35588796
[TBL] [Abstract][Full Text] [Related]
20. [Circulating lymphocyte subsets in patients with lung cancer and their prognostic value].
Luo J; Ling Z; Mao W
Zhongguo Fei Ai Za Zhi; 2011 Aug; 14(8):669-73. PubMed ID: 21859548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
